Drug Trial Radar · NCT07782970
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
218
Planned (sponsor's estimate)
Start
Sep 28, 2026
Primary completion
Mar 6, 2029
Study completion Oct 30, 2029
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Aug 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to assess the efficacy and safety of GSK5784283 administered as add-on maintenance therapy to participants with CRSwNP.
Conditions
- Nasal Polyps
Interventions
GSK5784283Drug
GSK5784283 will be administered.
PlaceboDrug
Placebo will be administered.
Standard of CareDrug
Standard of Care will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in total endoscopic nasal polyps (NP) score at Week 52Time frame: Baseline and Week 52
- Change from Baseline in mean nasal obstruction score using Verbal Response Scale (VRS) from Week 51 through to Week 52Time frame: Baseline, Weeks 51 to 52 (time - average)
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Tucson, Arizona · Recruiting
GSK Investigational Site
Los Angeles, California · Recruiting
GSK Investigational Site
Louisville, Kentucky · Recruiting
GSK Investigational Site
Tulsa, Oklahoma · Recruiting
GSK Investigational Site
Spartanburg, South Carolina · Recruiting
GSK Investigational Site
Gunma, Japan · Recruiting
GSK Investigational Site
Nagano, Japan · Recruiting
GSK Investigational Site
Nagano, Japan · Recruiting
GSK Investigational Site
San Juan, Puerto Rico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.